Lipid formulated compositions and mehods for inhibiting expression of a gene from the ebola virus
申请人:Alnylam Pharmaceuticals Inc.
公开号:EP2810643A2
公开(公告)日:2014-12-10
The invention relates to lipid formulated double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
本发明涉及用于抑制埃博拉病毒基因表达的脂质配制双链核糖核酸(dsRNA)。